Genovis (Q4 initial take): In line with our estimates - Redeye

As anticipated, Genovis’ year-end report showcased robust top-line momentum, with sharp sales growth following the SEK11m ADC-order announced in Q4. The report aligned with our estimates across the board and we do not anticipate making any material revisions in the wake of the release.

Länk till analysen i sin helhet: https://www.redeye.se/research/1146004/genovis-q4-initial-take-in-line-with-our-estimates?utm_source=finwire&utm_medium=RSS